PROSPECTS AND OPPORTUNITIES
Analgesics is expected to see modest value growth amid stable demand and product innovation
Value sales of analgesics are expected to increase modestly over the forecast period. This slight growth will primarily be driven by ongoing price increases; however, these are likely to stabilise and will not match the sharp rises observed between 2023 and 2025.
Wearable technology may support more targeted and preventative use of analgesics
In the context of the broader consumer health market, analgesics will remain one of the chief beneficiaries of the growing willingness of Hungarians to self-medicate over the forecast period. This is partly because mild-to-moderate pain and fever are among the minor ailments people are most likely to experience and seek immediate relief from.
Innovation will remain a strategic focus for leading analgesics manufacturers
Continued innovation in analgesics will remain a key focus for leading manufacturers, as they aim to provide consumers with products that offer rapid pain relief and maintain a competitive edge. Rather than introducing entirely new formulations, which often require lengthy approval processes, manufacturers are more likely to concentrate on enhancing the composition of existing products to deliver improved efficacy and faster onset of action.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Hungary with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Hungary, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Hungary report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Hungary?
- Which are the leading brands in Analgesics in Hungary?
- How are products distributed in Analgesics in Hungary?
- How has the regulatory and operating environment for Analgesics changed in Hungary?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Hungary - Category analysis
KEY DATA FINDINGS
Analgesics record strong value growth amid rising self-medication trends
Sanofi-Aventis retains its lead, but GlaxoSmithKline is the most dynamic player
Pharmacies remain dominant for analgesics while retail e-commerce shows early signs of growth
Analgesics is expected to see modest value growth amid stable demand and product innovation
Wearable technology may support more targeted and preventative use of analgesics
Innovation will remain a strategic focus for leading analgesics manufacturers
Consumer Health in Hungary - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!